Zeo ScientifiX Files 8-K with Financials
Ticker: ZEOX · Form: 8-K · Filed: Nov 15, 2024 · CIK: 1557376
Sentiment: neutral
Topics: 8-K, financials, disclosure
TL;DR
Zeo ScientifiX dropped an 8-K, check the financials.
AI Summary
Zeo ScientifiX, Inc. filed an 8-K on November 15, 2024, reporting under Regulation FD and including financial statements and exhibits. The company, formerly known as Organicell Regenerative Medicine, Inc., Biotech Products Services & Research, Inc., and BESPOKE TRICYCLES INC, is incorporated in Nevada and has its principal executive offices in Davie, Florida.
Why It Matters
This filing provides updated information and financial disclosures for Zeo ScientifiX, Inc., which is important for investors to assess the company's current status and performance.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, which typically contains standard disclosures and does not indicate any immediate or significant new risks.
Key Players & Entities
- Zeo ScientifiX, Inc. (company) — Registrant
- Organicell Regenerative Medicine, Inc. (company) — Former company name
- Biotech Products Services & Research, Inc. (company) — Former company name
- BESPOKE TRICYCLES INC (company) — Former company name
- November 15, 2024 (date) — Filing date
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing is made pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 and includes disclosures under Regulation FD, as well as financial statements and exhibits.
When was the earliest event reported in this filing?
The date of the earliest event reported is November 15, 2024.
What is Zeo ScientifiX, Inc.'s state of incorporation?
Zeo ScientifiX, Inc. is incorporated in Nevada.
What are the company's principal executive offices?
The company's principal executive offices are located at 3321 College Avenue, Suite 246, Davie, Florida.
What were some of Zeo ScientifiX, Inc.'s previous names?
Zeo ScientifiX, Inc. was formerly known as Organicell Regenerative Medicine, Inc., Biotech Products Services & Research, Inc., and BESPOKE TRICYCLES INC.
Filing Stats: 641 words · 3 min read · ~2 pages · Grade level 10.7 · Accepted 2024-11-15 08:30:29
Filing Documents
- zeoscientifix_8k.htm (8-K) — 30KB
- zeoscientifix_ex99-1.htm (EX-99.1) — 15KB
- ex99-1_001.jpg (GRAPHIC) — 219KB
- ex99-1_002.jpg (GRAPHIC) — 608KB
- ex99-1_003.jpg (GRAPHIC) — 394KB
- ex99-1_004.jpg (GRAPHIC) — 381KB
- ex99-1_005.jpg (GRAPHIC) — 220KB
- ex99-1_006.jpg (GRAPHIC) — 447KB
- ex99-1_007.jpg (GRAPHIC) — 511KB
- ex99-1_008.jpg (GRAPHIC) — 546KB
- ex99-1_009.jpg (GRAPHIC) — 422KB
- 0001829126-24-007559.txt ( ) — 5080KB
- ocel-20241115.xsd (EX-101.SCH) — 3KB
- ocel-20241115_lab.xml (EX-101.LAB) — 33KB
- ocel-20241115_pre.xml (EX-101.PRE) — 22KB
- zeoscientifix_8k_htm.xml (XML) — 3KB
01
Item 7.01 Regulation FD Disclosure. On November 15, 2024, Robin L. Smith, M.D., M.B.A., a co-founder of Exotropin, LLC (" Exotropin "), will be conducting a presentation entitled " Exosomes are the new Frontier in Aesthetics: Not All Exosomes are Alike " at the Medical Aesthetics Professionals (" MAP ") meeting being held in Scottsdale, Arizona., Exotropin is a privately-held developer of advanced cosmeceuticals using exosomes and other proprietary technology. ZEO holds a minority equity interest in Exotropin and is collaborating with Exotropin on the development of various products, including, ZEO HAIR GROW Powered By Exotropin, which is being introduced at the MAP meeting and which is featured in the presentation. A copy of the PowerPoint slides pertaining to the ZEO HAIR GROW Powered By Exotropin to be used in connection with Dr. Smith's presentation is attached as Exhibit 99.1 to this Report. The foregoing information, including the PowerPoint presentation attached as Exhibit 99.1 to this Report, is being furnished pursuant to Item 7.01 of this Current Report and shall not be deemed " filed " for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended or incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1* November 15, 2024 PowerPoint Presentation 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) * Furnished but not filed. 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: November 15, 2024 ZEO SCIENTIFIX, INC. By: /s/ Ian T. Bothwell Ian T. Bothwell Interim Chief Executive Officer and Chief Financial Officer 2